Share
print this page decrease the text size increase the text size

Advisory committees on medicines & chemicals scheduling (ACMS & ACCS)

Advisory Committee on Medicines Scheduling (ACMS) & Advisory Committee on Chemicals Scheduling (ACCS)

16 January 2013

Role of the ACMS and the ACCS

Scheduling is a classification system that controls how medicines and chemicals are accessible to consumers. Medicines and chemicals are grouped into Schedules according to the appropriate level of regulatory control over their availability (e.g. Schedule 4 - medicines available only by prescription; Schedule 2 - medicines available over the counter in pharmacies).

Under revised scheduling arrangements, which took effect on 1 July 2010, the Secretary to the Department of Health and Ageing (DoHA) (or the Secretary's delegate) superseded the National Drugs and Poisons Schedule Committee (NDPSC) as the decision maker for the scheduling of medicines and chemicals. The revised arrangements also established two expert advisory committees, the Advisory Committee on Medicines Scheduling (ACMS) and the Advisory Committee on Chemicals Scheduling (ACCS), as statutory committees under the Therapeutic Goods Act 1989 (the Act) to advise and make recommendations to the Secretary of the DoHA (or delegate) on the level of access required for medicines and chemicals.

Committee membership

Under the Therapeutic Goods Regulations 1990 (the Regulations), each Committee comprises of nine nominated members and no more than six appointed members.

Under the Act, the Commonwealth, each State, the Australian Capital Territory and the Northern Territory are entitled to nominate a member on each of these Committees. These Committee members are referred to as 'nominated' members.

Under the Regulations, the Minister must appoint no more than six additional members, selected through an open invitation process.

These Committee members are referred to as 'appointed' members. In accordance with the Regulations, all Committee members are required to have expertise in at least one of the following fields:

ACMS

  • the regulation of scheduled medicines in Australia
  • toxicology or pharmacology
  • clinical pharmacology
  • pharmacy medicine
  • medical practice
  • consumer health issues relating to the regulation of therapeutic goods
  • industry issues relating to the regulation of therapeutic goods

ACCS

  • the regulation of scheduled chemicals in Australia
  • veterinary medicines or veterinary pathology
  • toxicology
  • industrial or domestic chemicals
  • agricultural or veterinary chemicals
  • clinical aspects of human poisoning
  • occupational health issues, particularly as a medical practitioner
  • consumer health issues relating to the regulation of chemicals
  • industry issues relating to the regulation of chemicals

Committee members

Advisory Committee on Medicines Scheduling (ACMS) members

Chair

  • Mr John Jackson, BPharm, GDHP, MPH, FSHP

Appointed members

  • Prof Andrew H Dawson
  • Mrs Mary Emanuel, BPharm, MPS
  • A/Prof John Gullotta, AM
  • Mr John Daye, OAM
  • Mr David Newgreen

Nominated members

  • Dr Peter Bird
    Commonwealth
  • Mr Peter Gilfedder
    New South Wales
  • Ms Megan Smith
    Victoria
  • Dr Susan Ballantyne
    Queensland
  • Ms Jane Carpenter
    Western Australia
  • Ms Elizabeth Hender
    South Australia
  • Mr James Galloway
    Tasmania
  • Ms Gay Lavery
    Northern Territory
  • Ms Vivien Bevan
    ACT

Advisory Committee on Chemicals Scheduling (ACCS) members

Chair

  • Mr Peter Di Marco, BSc, PhD, FATS

Appointed members

  • Ms Bronwyn Capanna
  • Prof Andrew H Dawson
  • Dr Simon Robinson, BSc, BVetMed, MBA, MRCVS
  • Em Prof Alan A Seawright
  • A/Prof John Edwards

Nominated members

  • Mr Paul Harvey
    Commonwealth
  • Mr Peter Gilfedder
    New South Wales
  • Ms Megan Smith
    Victoria
  • Dr Gerard Neville
    Queensland
  • Ms Jane Carpenter
    Western Australia
  • Dr David Simon
    South Australia
  • Mr James Galloway
    Tasmania
  • Ms Gay Lavery
    Northern Territory
  • Ms Vivien Bevan
    ACT

ACMS and ACCS meeting dates & decisions timeframes

It is anticipated that the ACMS and ACCS will hold three face to face meetings annually. However, this will ultimately be determined by the individual and/or joint meeting agendas of proposals referred to the Committees by the delegate.

Stakeholders should note that the following timetable outlines the anticipated administrative timeframes associated with matters referred by the delegates to an expert advisory committee meeting. This timetable also reflects public consultation timeframes as required by legislation.

  February 2012 June 2012 October 2012 March 2013 July 2013 November 2013
General scheduling applications1
Lodgement deadline2 for scheduling applications 4 Oct 2011 14 Feb 2012 5 Jun 2012 23 Oct 2012 19 Mar 2013 23 Jul 2013
Public Notice3 pre-meeting submissions.
Inviting public comment on proposals referred to the Committees by the scheduling delegate
14 Dec 2011 26 Apr 2012 14 Aug 2012 29 Nov 2012 24 Apr 2013 29 Aug 2013
Public comment due 19 Jan 2012 25 May 2012 12 Sep 2012 17 Jan 2013 23 May 2013 26 Sep 2013
Agvet and delegate-initiated scheduling applications4
Lodgement deadline5 for agvet scheduling applications n/a n/a n/a 14 Dec 2012 9 May 2013 12 Sep 2013
Public Notice6 pre-meeting submissions.
Inviting public comment on proposals referred to the Committees by the scheduling delegate
n/a n/a n/a 7 Feb 2013 13 Jun 2013 17 Oct 2013
Public comment due n/a n/a n/a 7 Mar 2013 11 Jul 2013 14 Nov2013
2012-2013 ACCS and ACMS meeting dates
ACCS meeting 21 Feb 2012 27 Jun 2012 24 Oct 2012 19 Mar 2013 23 Jul 2013 26 Nov 2013
ACMS-ACCS joint meeting nil 27 Jun 2012 24 Oct 2012 20 Mar 2013
(if applicable)
24 Jul 2013
(if applicable)
27 Nov 2013
(if applicable)
ACMS meeting 22 Feb 2012 27 Jun 2012 24 & 25 Oct 2012 20 or 21 Mar 2013 24 or 25 Jul 2013 27 or 28 Nov 2013
Anticipated timetable for delegate's decision-making following ACMS/ACCS consideration
Public Notice of delegate's interim decision7
Inviting further public comment
26 Apr 2012 5 Sep 2012 19 Dec 2012 23 May 2013 26 Sep2013 20 Feb 2014
Public comment due 10 May 2012 19 Sep 2012 11 Jan 2013 6 June 2013 14 Oct 2013 6 Mar 2014
Public Notice of delegate's final decision 30 May 2012 10 Oct 2012 6 Feb 2013 27 June 2013 31 Oct 2013 27 Mar 2014
Anticipated that the delegate's final decisions following ACMS/ACCS consideration could be included in the following SUSMP Amendments, unless otherwise decided by the delegate (likely to occur frequently)
SUSMP Amendment and effective date SUSMP No.3
Amendments No. 1&2
1 Sep 2012
SUSMP No.3
Amendment No. 3
1 Jan 2013
SUSMP No.3
Amendment No.4
1 May 2013
SUSMP No.4
Amendment No.1
1 Sep 2013
SUSMP No.4
Amendment No.2
1 Jan 2014
SUSMP No.4
Amendment No.3
1 May 2014
  1. General scheduling applications
    General scheduling applications are those applications proposing to amend the Poisons Standard and must be supported by sufficient information and be in a form approved by the Secretary.
  2. Lodgement deadline
    Each applicant is required to lodge an application for consideration by a Scheduling Delegate 18 weeks before an advisory committee meeting. Not all applications are referred to a committee meeting; in some instances the delegate may make a delegate-only decision.
  3. Public Notice - pre-meeting submissions
    The Public Notice provides the opportunity for public comment on the scheduling proposals that have been referred to the advisory committees for advice. The Public Notice is open for consultation on the TGA website for a period of 20 business days
  4. Agvet and delegate-initiated Scheduling Applications
    Applications related to agricultural and veterinary chemicals (agvet) must be referred by the Australian Pesticides and Veterinary Medicines Authority (APVMA).
    Delegate-initiated applications are those that the delegate themselves have referred to the advisory committees for advice.
  5. Lodgement deadline
    Agvet applications are required to be lodged for consideration by a Scheduling Delegate 7 weeks before an advisory committee meeting. Not all applications are referred to a committee meeting; in some instances the delegate may make a delegate-only decision.
    There is no lodgement deadline for delegate-initiated applications.
  6. Public Notice - pre-meeting submissions
    The Public Notice provides the opportunity for public comment on the scheduling proposals that have been referred to the advisory committees for advice. The Public Notice is open for consultation on the TGA website for a period of 20 business days.
  7. Public Notice - delegate's interim decision
    Persons who provide comment at the Public Notice-pre-meeting submission stages3,6 are then also invited to comment on the delegate's interim decision and have 10 business days to respond.

Scheduling secretariat

Secretariat services are provided by the DoHA Office of Chemical Safety and Environmental Health. The contact details for the Secretariat are:

Email smp@health.gov.au
Phone +61 2 6289 2659
Fax +61 2 6289 2650
Postal address The Secretary
Medicines and Poisons Scheduling Secretariat
Office of Chemical Safety (MDP 88)
Department of Health and Ageing
GPO Box 9848
Canberra ACT 2600
Australia
Street address
(for deliveries)
Department of Health and Ageing
Level 5, Scarborough House
Atlantic Street
Woden ACT 2606
Australia

Top of page

Content last updated: Wednesday, 16 January 2013

Content last reviewed: Wednesday, 16 January 2013

Web page last updated: Wednesday, 16 January 2013

URL: http://www.tga.gov.au/about/committees-acmcs.htm

Site navigation

Safety information

Consumers

Health professionals

Industry

About the TGA

News room